Emergent BioSolutions Inc. — Director's Dealing 2018

Apr 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-04-17

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-17	Common Stock	M	7893	$13.37	Acquired	31303	Direct
2018-04-17	Common Stock	S	7893	$55.00	Disposed	23410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-17	Employee Stock Option (Right to Buy)	$13.37	M	7893	Disposed	2019-05-16	Common Stock (7893)	Direct

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: Consists of an option granted under the company's stock incentive plan as amended and restated.

F3: The option grant is fully vested.